SLC1A5 and acute myeloid leukemia: Second, as for the signal regulators, IGF2BP2 can affect the glutamine metabolism pathway by regulating the expression of key targets, such as Myc, GPT2, and solute carrier family 1 member 5 (SLC1A5), which in turn promotes AML development and LSC/LIC self-renewal 111].